Patents by Inventor Beverly Torok-Storb

Beverly Torok-Storb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130122022
    Abstract: The amino acid sequence of the heavy chain polypeptide and the light chain polypeptide of the STRO-1 antibody is disclosed. Also disclosed are methods for detecting and isolating cells expressing the STRO-1 cell surface protein.
    Type: Application
    Filed: December 19, 2011
    Publication date: May 16, 2013
    Inventor: Beverly Torok-Storb
  • Patent number: 8101155
    Abstract: The amino acid sequence of the heavy chain polypeptide and the light chain polypeptide of the STRO-1 antibody is disclosed. Also disclosed are methods for detecting and isolating cells expressing the STRO-1 cell surface protein.
    Type: Grant
    Filed: January 16, 2007
    Date of Patent: January 24, 2012
    Assignee: Fred Hutchinson Cancer Research Center
    Inventor: Beverly Torok-Storb
  • Publication number: 20090068096
    Abstract: The amino acid sequence of the heavy chain polypeptide and the light chain polypeptide of the STRO-1 antibody is disclosed. Also disclosed are methods for detecting and isolating cells expressing the STRO-1 cell surface protein.
    Type: Application
    Filed: January 16, 2007
    Publication date: March 12, 2009
    Applicant: FRED HUTCHINSON CANCER RESEARCH CENTER
    Inventor: Beverly Torok-Storb
  • Patent number: 7129086
    Abstract: Immortalized human stromal cell lines sustain and expand human hematopoietic precursor cells. The precursor cells are obtained from a blood product and inoculated into a culture medium conditioned by exposure to a human stromal cell line. Preferred human stromal cell lines secrete SCF, LIF, MIP1?, and IL-6, as exemplified by a human stromal cell line designated HS-1. The conditioned culture medium may be supplemented with additional growth factors, such as interleukin-3. After expansion the human hematopoietic precursor cells are harvested and returned to a patient or frozen and stored. The immortalized human stromal cell lines can also be used as feeder layers in ex vivo bone marrow cultures or in colony forming assays.
    Type: Grant
    Filed: June 4, 2002
    Date of Patent: October 31, 2006
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Beverly Torok-Storb, Bryan A. Roecklein, Gretchen Johnson
  • Publication number: 20020197717
    Abstract: Immortalized human stromal cell lines sustain and expand human hematopoietic precursor cells. The precursor cells are obtained from a blood product and inoculated into a culture medium conditioned by exposure to a human stromal cell line. Preferred human stromal cell lines secrete SCF, LIF, MIP1&agr;, and IL-6, as exemplified by a human stromal cell line designated HS-1. The conditioned culture medium may be supplemented with additional growth factors, such as interleukin-3. After expansion the human hematopoietic precursor cells are harvested and returned to a patient or frozen and stored. The immortalized human stromal cell lines can also be used as feeder layers in ex vivo bone marrow cultures or in colony forming assays.
    Type: Application
    Filed: June 4, 2002
    Publication date: December 26, 2002
    Applicant: Fred Hutchinson Cancer Research Center
    Inventors: Beverly Torok-Storb, Bryan A. Roecklein, Gretchen Johnson
  • Patent number: 6103522
    Abstract: Immortalized human stromal cell lines sustain and expand human hematopoietic precursor cells. The precursor cells are obtained from a blood product and inoculated into a culture medium conditioned by exposure to a human stromal cell line. Preferred human stromal cell lines secrete SCF, LIF, MIP1.alpha., and IL-6, as exemplified by a human stromal cell line designated HS-1. The conditioned culture medium may be supplemented with additional growth factors, such as interleukin-3. After expansion the human hematopoietic precursor cells are harvested and returned to a patient or frozen and stored. The immortalized human stromal cell lines can also be used as feeder layers in ex vivo bone marrow cultures or in colony forming assays.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: August 15, 2000
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Beverly Torok-Storb, Bryan A. Roecklein, Gretchen Johnson
  • Patent number: 5879940
    Abstract: Immortalized human stromal cell lines sustain and expand human hematopoietic precursor cells. The precursor cells are obtained from a blood product and inoculated into a culture medium conditioned by exposure to a human stromal cell line. Preferred human stromal cell lines secrete SCF, LIF, MIP1.alpha., and IL-6, as exemplified by a human stromal cell line designated HS-1. The conditioned culture medium may be supplemented with additional growth factors, such as interleukin-3. After expansion the human hematopoietic precursor cells are harvested and returned to a patient or frozen and stored. The immortalized human stromal cell lines can also be used as feeder layers in ex vivo bone marrow cultures or in colony forming assays.
    Type: Grant
    Filed: May 23, 1997
    Date of Patent: March 9, 1999
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Beverly Torok-Storb, Bryan A. Roecklein, Gretchen Johnson